scorecardresearchFundsmith Emerging Equities sells Thyrocare shares worth ₹36 crore
Mintgenie

Fundsmith Emerging Equities sells Thyrocare shares worth ₹36 crore

Team MintGenie
Updated: 30 Aug 2022, 08:09 AM IST
TL;DR.

Fundsmith Emerging Equities Trust Plc sold 3,20,000 shares on BSE and 2,68,707 shares on NSE, amounting to a 1.1 per cent stake in the company, as per the bulk deal data available with the National Stock Exchange and BSE.

A vegetable vendor counts Indian rupee banknotes at a vegetable market in Mumbai, India, on Wednesday, July 20, 2022. The rupee slid to all-time low of 80.06 per dollar on Tuesday, and has lost 2.4% over the past month, the third-worst performing Asian currency over the period. Photographer: Dhiraj Singh/Bloomberg

A vegetable vendor counts Indian rupee banknotes at a vegetable market in Mumbai, India, on Wednesday, July 20, 2022. The rupee slid to all-time low of 80.06 per dollar on Tuesday, and has lost 2.4% over the past month, the third-worst performing Asian currency over the period. Photographer: Dhiraj Singh/Bloomberg

(PTI) An entity on Monday offloaded 5.88 lakh shares of diagnostic chain Thyrocare Technologies Ltd for ₹36 crore through an open market transaction.

Fundsmith Emerging Equities Trust Plc sold 3,20,000 shares on BSE and 2,68,707 shares on NSE, amounting to a 1.1 per cent stake in the company, as per the bulk deal data available with the National Stock Exchange and BSE.

The shares were disposed of at an average price of ₹615.14 apiece on BSE and ₹614.79 on NSE, taking the combined transaction value to ₹36.20 crore.

However, buyer(s) of the shares could not be ascertained.

As of June quarter, Fundsmith held 1.15 per cent stake in the company, shareholding pattern showed with the exchange.

Shares of Thyrocare Technologies closed 2.97 per cent lower at ₹610 apiece on BSE and slipped 2.65 per cent on NSE.

First Published: 30 Aug 2022, 08:09 AM IST

Topics to follow